LIN Financial Statements & Analysis
Complete financial statements for LIN including income statement, balance sheet, and cash flow statement. Analyze LIN's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
55
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
0.5% ↑
Net Income
5.9% ↑
Gross Margin
4.2% ↑
Operating Margin
5.6% ↑
Balance Sheet
Current Ratio
10.8% ↑
Debt to Equity
16.0% ↓
Asset Turnover
1.3% ↑
Cash Flow
Operating Cash Flow
1.3% ↑
Net Cash Flow
124.1% ↑
Free Cash Flow
-10.7% ↓
Cash Flow to Debt
-9.0% ↓
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 32.85B | 33.01B | 0.5% | |
| Gross Profit | 11.55B | 12.08B | 4.6% | |
| Operating Income | 8.11B | 8.60B | 6.0% | |
| Net Income | 6.20B | 6.57B | 5.9% | |
| EPS | 12.7 | 13.71 | 8.0% | |
| EBITDA | 12.29B | 12.92B | 5.1% | |
| Gross Margin | 35.14% | 36.61% | 4.2% | |
| Operating Margin | 24.67% | 26.04% | 5.6% | |
| Net Income Margin | 18.87% | 19.89% | 5.4% | |
| R&D Expenses | 146.00M | 150.00M | 2.7% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 33.01B | 32.85B | 33.36B | 30.79B | 27.24B |
| Gross Profit | 12.08B | 11.55B | 9.71B | 8.62B | 7.23B |
| Operating Income | 8.60B | 8.11B | 6.46B | 5.28B | 3.89B |
| Net Income | 6.57B | 6.20B | 4.15B | 3.83B | 2.50B |
| EPS | 13.71 | 12.7 | 8.3 | 7.4 | 4.75 |
| EBITDA | 12.92B | 12.29B | 9.94B | 9.89B | 8.12B |
| Gross Margin | 36.61% | 35.14% | 29.10% | 27.98% | 26.55% |
| Operating Margin | 26.04% | 24.67% | 19.36% | 17.16% | 14.28% |
| Net Income Margin | 19.89% | 18.87% | 12.43% | 12.42% | 9.18% |
| R&D Expenses | 150.00M | 146.00M | 143.00M | 143.00M | 152.00M |